A retrospective,multicentre,observational study to evaluate the effectiveness and safety of Sofosbuvir and Simeprevir with or without Ribavirin in Hepatitis C infected patients with or without HIV infection
Latest Information Update: 29 Mar 2017
Price :
$35 *
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 29 Mar 2017 New trial record
- 01 Mar 2017 Results published in the International Journal of Antimicrobial Agents